Obrist R - Search Results

1

Intraperitoneal immunotherapy of human ovarian carcinoma with Corynebacterium parvum.

Bast RC Jr, Berek JS, Obrist R, Griffiths CT, Berkowitz RS, Hacker NF, Parker L, Lagasse LD, Knapp RC. Bast RC Jr, et al. Among authors: obrist r. Cancer Res. 1983 Mar;43(3):1395-401. Cancer Res. 1983. PMID: 6825108

2

Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum.

Berek JS, Knapp RC, Hacker NF, Lichtenstein A, Jung T, Spina C, Obrist R, Griffiths CT, Berkowitz RS, Parker L, et al. Berek JS, et al. Among authors: obrist r. Am J Obstet Gynecol. 1985 Aug 15;152(8):1003-10. doi: 10.1016/0002-9378(85)90548-4. Am J Obstet Gynecol. 1985. PMID: 2992276

3

Monocyte chemotaxis mediated by formyl-methionyl-leucyl-phenylalanine conjugated with monoclonal antibodies against human ovarian carcinoma.

Obrist R, Reilly R, Leavitt T, Knapp RC, Bast RC Jr. Obrist R, et al. Int J Immunopharmacol. 1983;5(4):307-14. doi: 10.1016/0192-0561(83)90033-4. Int J Immunopharmacol. 1983. PMID: 6629591

4

Enhanced arachidonic acid lipoxygenation by K562 cells stimulated with 12-O-tetradecanoylphorbol-13-acetate.

Valone FH, Obrist R, Tarlin N, Bast RC Jr. Valone FH, et al. Among authors: obrist r. Cancer Res. 1983 Jan;43(1):197-201. Cancer Res. 1983. PMID: 6401164

5

Chemotactic anti-tumor antibodies: in vitro results with four different antibody preparations.

Obrist R, Obrecht JP, Bast RC Jr, Sandberg AL. Obrist R, et al. Adv Exp Med Biol. 1985;186:827-32. doi: 10.1007/978-1-4613-2463-8_100. Adv Exp Med Biol. 1985. PMID: 4050600 No abstract available.

6

Chemotactic monoclonal antibody conjugates: a comparison of four different f-Met-peptide-conjugates.

Obrist R, Schmidli J, Obrecht JP. Obrist R, et al. Biochem Biophys Res Commun. 1988 Sep 30;155(3):1139-44. doi: 10.1016/s0006-291x(88)81259-2. Biochem Biophys Res Commun. 1988. PMID: 3263121

7

Conjugation behaviour of different monoclonal antibodies to f-methionyl-leucyl-phenylalanine.

Obrist R, Schmidli J, Obrecht JP. Obrist R, et al. Int J Immunopharmacol. 1986;8(6):629-32. doi: 10.1016/0192-0561(86)90035-4. Int J Immunopharmacol. 1986. PMID: 3793327

8

In vitro effects of antitumor antibody--chemotactic factor complexes.

Obrist R, Sandberg AL. Obrist R, et al. Clin Immunol Immunopathol. 1982 Oct;25(1):91-102. doi: 10.1016/0090-1229(82)90168-4. Clin Immunol Immunopathol. 1982. PMID: 6295673 No abstract available.

9

In vitro and in vivo effects of anti-tumor antibody covalently coupled to a chemotactic peptide.

Sandberg AL, Obrist R, Mergenhagen SE. Sandberg AL, et al. Among authors: obrist r. Agents Actions Suppl. 1983;12:234-50. doi: 10.1007/978-3-0348-9352-7_14. Agents Actions Suppl. 1983. PMID: 6340437 Review. No abstract available.

10

Enhancement of macrophage invasion of tumors by administration of chemotactic factor-antitumor antibody conjugates.

Obrist R, Sandberg AL. Obrist R, et al. Cell Immunol. 1983 Oct 1;81(1):169-74. doi: 10.1016/0008-8749(83)90222-8. Cell Immunol. 1983. PMID: 6651932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters